QuantiFluo™ Pepsin Inhibitor Assay Kit

Overview

or evaluation of drugs and screening of potential inhibitors to pepsin proteases. Safe. Non-radioactive assay. Homogeneous and Homogenous “Mix-incubate-measure” type assay. No wash and reagent transfer steps are involved. Robust and. The assay uses FL485/530nm or FP485/530nm for signal readout. Compatible sample input includes Compounds that affect pepsin activity. Typical stated assay timing is 45 min.

Key elements and design rationale

• Readout format: FL485/530nm or FP485/530nm supports plate-based signal acquisition and consistent comparison across matched samples.
• Sample compatibility: The stated sample scope includes Compounds that affect pepsin activity, which is useful when aligning matrix type with calibration and control design.
• Workflow timing: The listed assay time of 45 min helps frame batch planning, replicate handling, and plate throughput.
• Feature emphasis: Safe. Non-radioactive assay.

Additional feature notes highlight Homogeneous and convenient. Homogenous “Mix-incubate-measure” type assay. No wash and reagent transfer steps are involved; Robust and High-throughput. Can be readily automated to assay thousands of samples per day. Robust assay with a Z’ factor of > 0.7. Available format information for this listing includes 200 Tests in 96-well plate (Custom bulk sizes available upon request).

Biological background

This product is centered on measurement of pepsin inhibitor within the matrices described for the assay. In practice, datasets from this type of format are typically interpreted by comparing relative signal, activity, or abundance across matched control and experimental groups rather than relying on a single value in isolation. Careful alignment of sample matrix, incubation window, and calibration strategy is important when comparing results across plates, operators, or study days.

More details

PEPSIN(EC 3.4.23.1) is a digestive, serine protease that hydrolyzes dietary proteins in many eukaryotic and prokaryotic organisms. Pepsin predominantly cleaves peptide chains at the amino side of the aromatic phenylalanine, tryptophan, and tyrosine amino acids. BioAssay Systems’ QuantiFluo™ Pepsin Inhibitor Assay Kit uses a fluorescein isothiocyanate (FITC)-labeled synthetic substrate. The fluorescein label is highly quenched. Upon digestion by pepsin present in the sample, the substrate is cleaved into smaller peptides, which abolishes the quenching of the fluorescence label. The fluorescence or fluorescence polarization (FP) of the FITC-labeled fragments is measured at λ_ex/em= 485/530 nm. Inhibition is determined by the decrease in fluorescence.

Detection method

Fluorescent (FL 485/530 nm).

Procedures and timing

Stated procedure or timing information: 45 min.

Screening services

BioAssay Systems offers comprehensive Pepsin lead discovery services, including compound library screening, inhibitor profiling, and high-throughput assays to identify potential drug candidates. We provide detailed analyses of compound activity, potency, and selectivity, supporting hit-to-lead and lead optimization efforts. Please contact us for more details at Service .

Research relevance and current trends

• Plate-based quantification and side-by-side group comparison remain central use cases for this assay format.
• The product notes emphasize multi-sample throughput, making it relevant for screening-oriented and larger batch comparison studies.
• The description supports intervention-focused study designs in which researchers compare baseline and perturbed conditions.

Common research applications

• Quantify pepsin inhibitor in compounds that affect pepsin activity by FL485/530 nm or FP485/530 nm readout.
• Compare treatment or phenotype groups using matched compounds that affect pepsin activity handling.
• Monitor time-course or pre/post changes in compounds that affect pepsin activity across study conditions.

Interpretation is usually strongest when signal changes are assessed alongside matrix-matched controls, replicate agreement, and the assay's stated analytical window.

Notes for experimental interpretation

• Matrix composition, background signal, and sample handling can influence apparent response; compare like-with-like whenever possible.
• Use appropriate blanks, controls, and replicate wells to distinguish biological differences from plate, reagent, or handling variability.

For laboratories requiring additional technical capacity, we provide scientific support services including assay execution, method guidance, product sourcing, and customization to align the assay with specific experimental objectives. If you need assistance selecting the appropriate kit configuration, adapting the workflow to your application, or identifying related research services, please click Talk to a Scientist, email support@biohippo.com, or review our Research Services; a member of our scientific team will follow up with recommendations tailored to your study.